Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 rando... von Vermorken, Jan B, Dr, Stöhlmacher-Williams, Jan, MD, Davidenko, Irina, MD, Licitra, Lisa, MD, Winquist, Eric, MD, Villanueva, Cristian, MD, Foa, Paolo, MD, Rottey, Sylvie, MD, Skladowski, Krzysztof, MD, Tahara, Makoto, MD, Pai, Vasant R, MD, Faivre, Sandrine, MD, Blajman, Cesar R, MD, Forastiere, Arlene A, MD, Stein, Brian N, MBBS, Oliner, Kelly S, PhD, Pan, Zhiying, PhD, Bach, Bruce A, MD

Volltext

Vandetanib Versus Placebo in Patients With Advanced Non–Small-Cell Lung Cancer After Prior Therapy With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor: A Randomized,... von Lee, Jin Soo, Hirsh, Vera, Park, Keunchil, Qin, Shukui, Blajman, Cesar R, Perng, Reury-Perng, Chen, Yuh-Min, Emerson, Laura, Langmuir, Peter, Manegold, Christian

Volltext

Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer von Pereira, Jose R, Fein, Luis, del Giglio, Auro, Blajman, César R, Richardet, Eduardo, Schwartsmann, Gilberto, Orlando, Mauro, Hall, Belinda J, West, Teena M, van Kooten, Maximiliano

Volltext

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer von Posner, Marshall R, Hershock, Diane M, Blajman, Cesar R, Mickiewicz, Elizabeth, Winquist, Eric, Gorbounova, Vera, Tjulandin, Sergei, Shin, Dong M, Cullen, Kevin, Ervin, Thomas J, Murphy, Barbara A, Raez, Luis E, Cohen, Roger B, Spaulding, Monica, Tishler, Roy B, Roth, Berta, Viroglio, Rosana del Carmen, Venkatesan, Varagur, Romanov, Ilya, Agarwala, Sanjiv, Harter, K. William, Dugan, Matthew, Cmelak, Anthony, Markoe, Arnold M, Read, Paul W, Steinbrenner, Lynn, Colevas, A. Dimitrios, Norris, Charles M, Haddad, Robert I

Volltext

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 rando... von Vermorken, Jan B, Stoelmacher-Williams, Jan, Davidenko, Irina, Licitra, Lisa, Winquist, Eric, Villanueva, Cristian, Foa, Paolo, Rottey, Sylvie, Skladowski, Krzysztof, Tahara, Makoto, Pai, Vasant R, Faivre, Sandrine, Blajman, Cesar R, Forastiere, Arlene A, Stein, Brian N, Oliner, Kelly S, Pan, Zhiying, Bach, Bruce A

Volltext

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer von POSNER, Marshall R, HERSHOCK, Diane M, MURPHY, Barbara A, RAEZ, Luis E, COHEN, Roger B, SPAULDING, Monica, TISHLER, Roy B, ROTH, Berta, DEL CARMEN VIROGLIO, Rosana, VENKATESAN, Varagur, ROMANOV, Ilya, AGARWALA, Sanjiv, BLAJMAN, Cesar R, HARTER, K. William, DUGAN, Matthew, CMELAK, Anthony, MARKOE, Arnold M, READ, Paul W, STEINBRENNER, Lynn, DIMITRIOS COLEVAS, A, NORRIS, Charles M, HADDAD, Robert I, MICKIEWICZ, Elizabeth, WINQUIST, Eric, GORBOUNOVA, Vera, TJULANDIN, Sergei, SHIN, Dong M, CULLEN, Kevin, ERVIN, Thomas J

Volltext

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer von Ross, L., Eisen, A., Elsafy, F., Fielding, A., Friedman, S., Gianni, L., Phillips, K.-A., Singer, C.F., Toi, M., Park, Y.H., Yang, H., Mailliez, A., Nagy, T., Sonke, G.S., Sun, Q., Colleoni, M.A., Kaufman, B., Cameron, D., Campbell, C., Sevelda, Paul, Öhler, Leopold, Rumpold, Holger, Rautenberg, Beate, Boadle, David, Mackey, John, Niraula, Saroj, Randal d’Hondt, Papadimitriou, Konstantinos, Lazzaro, Mauricio Fernández, Pilnik, Norma, Varela, Mirta, Darsow, Maren, Park-Simon, Tjoung-Won, Terhaag, Jürgen, Salat, Christoph, Dieterich, Max, García Sáenz, José Ángel, Lanza, Angels Arcusa, Quiroga, Vanesa, Jañez, Noelia Martínez, Crusades, Gema Llort, Rodríguez, César, Cretella, Elisabetta, Jegannathen, Apurna, Ishida, Kazushige, Watanabe, Junichiro, Takada, Masahiro, Nakamura, Seigo, Aogi, Kenjiro, Tsugawa, Koichiro, Seaward, Samantha A., Carney, Jennifer Fu, Bobolis, Kristie A., Eisenberg, Peter D., Hofstatter, Erin W., McCarron, Edward C., Herbolsheimer, Pia, Meisel, Jane L., Jones, Cheryl F., Spector, David M., Lo, Shelly S., Cristofanilli, Massimo, Hahn, Olwen M., Oliff, Ira A., Ansari, Bilal, Sharma, Priyanka, Armstrong, Deborah K., VanderWoude, Amy, Friday, Bret E.B., T, Benjamin, Kuzma, Charles S., Radford, James E., Soori, Gamini S., Vogel, Victor G., Wilkinson, Mary, Qamar, Rubina, Loman, Niklas, Silander, Gustav, Abreu, Miguel, Ciruelos Gil, Eva María, Bermejo de las Heras, Begoña, Busch, Steffi, Thomalla, Jörg, Altena, Renske, Chen, Shou-Tung, Huang, Chiun-Sheng, Yeh, Dah-Cherng, Pottier, Virginie, Yang, Hongjian, Fu, Peifen, Wang, Yongsheng, Fan, Zhimin, Landherr, László, Yerushalmi, Rinat, Conte, Pierfranco, Ciccarese, Mariangela, Mackiewicz, Jacek, Kalinka, Ewa, Im, Seock-Ah, Lee, Kyoung Eun

Volltext

A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5‐fluorouracil with vinorelbine plus doxorubicin in the treatme... von Blajman, Cesar, Balbiani, L., Block, J., Coppola, F., Chacon, R., Fein, L., Bonicatto, S., Alvarez, A., Schmilovich, A., Delgado, F. M.

Volltext